OssDsign AB

OssDsign AB

OssDsign AB


Virdings allé 2,Uppsala 754 50

Type of Company



Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Holding Companies

Company Description

OssDsign AB designs and manufactures implants and material technology for bone replacement. It is an orthopedic medical device company that develops implantable products. It develops pioneering implants for bone healing with focus on cranial surgery. The firm's product OssDsign Cranio PSI is an implant for skull reconstruction. It uses new design solutions, material compositions, and manufacturing processes mainly based on proprietary bioceramic technologies. The company was by Håkan Gunnar Engqvist, Carl Thomas Engstrand, Bo Erik Qwarnstrom, and Jonas Åberg in May 2011 and is headquartered in Uppsala, Sweden.

Contact Data
Trying to get in touch with decision makers at OssDsign AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees



Chief Executive Officer

Chief Financial Officer

Director, Marketing & Business Development

Director, Technical Operations

Director-Clinical Engineering

Director, Supply & Production

Board of Directors

Venture Partner at IP Group Plc

Chief Executive Officer & Chief Investment Officer at Karolinska Development AB

Investment Director at Fouriertransform AB

Investment Manager at SEB Venture Capital

Co-Founder at OssDsign AB

Paths to OssDsign AB
Potential Connections via
Relationship Science
OssDsign AB
Details Hidden

Fouriertransform is an active, long-term manager which invests from their own balance sheet in automotive-related companies in all parts of the value chain and in all business phases. They focus exclusively on the automotive industry in Sweden.The firm seeks to invest up to SEK 150 million in automotive-related companies with an innovative product or service with growth potential on Swedish and global markets, an attractive underlying market with growth and good profitability prospects, entrepreneurial management focused on the company's growth and profitability, industrial partners capable of supporting their commercialization and expansion and good prospects for exit.Fouriertransform utilizes a range of financing solutions including share capital, profit-sharing loans and other capital participation. They typically take minority stakes in their investee companies, sometimes as the principal shareholder, sometimes as a traditional minority shareholder. They partner with investee management, developing a value-adding plan and ensuring adequate reporting and providing a sounding board for the CEO and the chairman of the board.They contribute expertise by placing qualified representatives (Fouriertransform employees or persons from Fouriertransform's network) on the boards of their investee companies.

Details Hidden

KD's investment approach aims to transfer life sciences innovations into commercial applications while improving human health. They are an early investor with the objective of being the lead investor. They generally maintain a significant position in their portfolio firms until exit. They endeavor to rapidly build value in high risk opportunities.Among key investment criteria, they seek innovations, either pharmaceutical or medical technology applications, which address unmet medical needs. KD looks for opportunities displaying a strong IP position, preferably with a patent application, as well as unique skills or processes.KD works closely with regional Nordic academic and research institutions. Their deal flow agreement with Karolinska Institutet Innovations ensures priority access of promising opportunities at a very early stage. In addition to capital infusion, the firm supports their investments through business development expertise, technical specialists and access to their wide-ranging professional network.

Details Hidden

SEB VC is an active, long-term manager which makes venture capital investments in growth companies in the technology, life science and industrial sectors, aiming to add competence and provide a network for investee companies. The firm focuses on companies which have a unique product or service with a sustainable competitive edge, a highly skilled management team who are also partners in the company and a business concept with international market potential.SEB VC takes a minority position in their investee companies, seeking board representation and making investments up to SEK 80 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by OssDsign AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of OssDsign AB's profile does not indicate a business or promotional relationship of any kind between RelSci and OssDsign AB.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/ossdsign-ab-1989531
  • https://relationshipscience.com/organization/ossdsign-ab-1989531